Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Its lead candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor being developed for obstructive and non-obstructive HCM. Reporting to the Head of Medical Affairs, the Associate Director/Director will own the publications function for BHB-1893. This hands-on, cross-functional role leads the strategy, planning, and execution of a multi-year publication and congress plan to build the evidence base supporting global development and a future launch. The role coordinates publications from concept through submission and publication, ensuring scientific quality, alignment, and timely delivery. It also leads reactive scientific communications supporting the global development and future launch of BHB-1893. Activities must uphold scientific integrity and comply with GPP, ICMJE, and applicable regulatory and industry guidelines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree